GLP-3 RT 10mg Peptides
Precision begins with materials you can trust, crafted for consistent performance in demanding research settings.
The Primavora GLP-3 RT lyophilized peptide arrives as a clean, laboratory-ready vial designed for controlled reconstitution and study. This single-ingredient format provides a total of 10mg GLP-3 RT in a stable, freeze-dried matrix, supporting reliable handling, clear labeling, and streamlined organization across research workflows.
- Each vial contains 10mg of GLP-3 RT, enabling targeted evaluation of receptor engagement, structure-activity relationships, stability, and other key assay parameters under well-defined laboratory conditions.
Developed for non-ingestible use in research environments, this lyophilized peptide offers a straightforward experience: a uniform, dry solid that reconstitutes cleanly when prepared according to your laboratory’s protocols. The single-vial, single-identity presentation supports accurate concentration calculations, method reproducibility, and controlled comparisons across experimental runs.
Primavora prioritizes material integrity from sourcing through final packaging. Each lot is verified for identity and purity, with tight release specifications aimed at ensuring consistency between vials and between batches. Vials are sealed with tamper-evident safeguards and labeled clearly to assist chain-of-custody, inventory tracking, and documentation requirements. As a USA-based research supplier, we emphasize rigorous standards, transparency, and dependable availability to help keep studies moving without compromise.
Intended Use: For laboratory research use only. Not for human or veterinary use, and not a drug, food, or cosmetic. Handle exclusively in controlled research settings by qualified personnel following applicable regulations, SOPs, and safety practices. Store and reconstitute according to your laboratory’s established procedures to preserve material quality and ensure consistent results. For added confidence, lot-level documentation is available upon request.
Choose Primavora when reliability matters. Our focus is straightforward—quality manufacturing, careful handling, and rigorous standards that support credible results. With GLP-3 RT 10mg lyophilized peptide vials, you can work with confidence in the material, concentrate on the data, and maintain the discipline your research demands.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-3 RT?
GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
What is GLP-3 RT typically studied for?
Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Prima Vora are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
